The Effect of Some Symptoms and Features During the Infection Period on the Level of Anxiety and Depression of Adults after Recovery from COVID-19

Abstract

Background: Considering the previous evidence regarding SARS/MERS outbreaks, ıt is expected that emergent psychiatric conditions such as mood disorders, anxiety, and depression disorders may occur in survivors of COVID-19. Objectives: In this study, the effects of clinical/neurological symptoms and sociodemographic characteristics of COVID-19 patients during the infection period on the level of anxiety/depression after recovery were investigated. Methods: Firstly, the socio-demographic characteristics of the participants and their clinical/ neurological symptoms during the infection period were determined. In addition, the Beck anxiety/depression scale was administered to the participants upon discharge. Then, the odds ratio of the variables was calculated by applying the Poisson regression method to determine the predictors affecting the level of anxiety/depression. Results: In this study, the clinical/neurological symptoms and the sociodemographic characteristics affecting the level of anxiety/depression were found to be associated with adults (mean age 45-years). The number of days of hospitalization was the only clinical feature that increased both anxiety and depression levels. In addition, post-discharge sleep disorder, headache, and alcohol use were found to be predictors of increased anxiety levels. In addition, smoking, the presence of a person with COVID-19 infection in the immediate vicinity, traveling in the last month before the illness, fever, and loss of smell during the infection period was found to increase the level of depression. Moreover, asthma was the only significant comorbidity that increased the anxiety level, while diabetes was the only comorbidity that increased the depression level. Conclusion: It is expected that this study will support social-psychological intervention and have some effects on reducing depressive/anxiety symptoms, which can vary widely in adults during stressful events.

Effect of ferritin, INR, and D-dimer immunological parameters levels as predictors of COVID-19 mortality: A strong prediction with the decision trees

“…COVID-19 has attracted attention for its higher infectivity and mortality than influenza [ 1 , 3 , 41 ]. The majority of infected patients had mild symptoms.…”

Machine Learning Sensors for Diagnosis of COVID-19 Disease Using Routine Blood Values for Internet of Things Application

“…COVID-19 has a higher mortality and infectivity than influenza [ 3 , 13 ]. The disease still causes death and continues to spread [ 1 , 6 , 15 ]. The use of vaccines did not stop the spread of the disease, and important mutations were detected in the structure of the virus during the epidemic [ 1 ].…”

“…Machine learning (ML) and AI studies based on RBVs features are a more economical and rapid alternative method for the early detection, diagnosis and prognosis of COVID-19 [ 7 , 11 , 12 ]. Previous studies have indicated that this disease can accompany multi-organ dysfunction and cause a variety of symptoms [ 3 , 13 , 14 , 15 ]. COVID-19 can cause severe pneumonia and severe ARDS due to inflammatory cytokine storms [ 5 , 14 ].…”

LogNNet model as a fast, simple and economical AI instrument in the diagnosis and prognosis of COVID-19

“…While new studies continue to diagnose SARS-CoV-2, many of these applications require specialized teams and specialized equipment, increasing the cost [9] , [10] , [11] , [12] . It is extremely important that new technological applications for the diagnosis and determination of the prognosis of the disease are easily accessible to every society and can be used quickly and effectively without creating an existence problem [ 10 , 11 , 13 ].…”